Rankings
▼
Calendar
CGEM Q4 2021 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
Q4 2021 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$34M
Net Income
-$33M
EPS (Diluted)
$-0.74
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$437M
Total Liabilities
$12M
Stockholders' Equity
$425M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$34M
-$29M
-17.7%
Net Income
-$33M
-$28M
-14.7%
← FY 2021
All Quarters
Q1 2022 →